Anzeige
Mehr »
Login
Sonntag, 17.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Solarbetriebene Krypto-Strategie lässt Aktie an einem Tag um 100% steigen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DQXY | ISIN: CA83307B1013 | Ticker-Symbol: VY4
Tradegate
15.11.24
21:02 Uhr
1,874 Euro
+0,017
+0,92 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
SNDL INC Chart 1 Jahr
5-Tage-Chart
SNDL INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,8101,87016.11.
1,8341,88015.11.
PR Newswire
25 Leser
Artikel bewerten:
(0)

SNDL Inc.: SNDL Reports Third Quarter 2024 Financial and Operational Results

Finanznachrichten News

The Company reports record Gross Margin and positive Cash Flow and
Free Cash Flow

CALGARY, AB, Nov. 5, 2024 /CNW/ - SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the third quarter ended September 30, 2024. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated.

SNDL has also posted a supplemental investor presentation on its website, found at https://sndl.com.

The Company will hold a conference call and webcast presentation at 10:00 a.m. EST (8:00 a.m. MST) on Tuesday, November 5, 2024. The conference call details can be found below.

THIRD QUARTER 2024 FINANCIAL AND OPERATIONAL HIGHLIGHTS

  • Net revenue for the third quarter of 2024 was $236.9 million, compared to $237.6 million in the third quarter of 2023, a decrease of 0.3%. This decrease was driven by market softness in the Liquor Retail segment, while both Cannabis Retail and Cannabis Operations segments posted strong growth. This represents an increase of 3.8% in net revenue quarter on quarter, as compared to net revenue of $228.1 million in the second quarter of 2024.

  • Achieved a gross profit of $63.0 million, representing a record gross margin of 26.6% of sales in the third quarter of 2024, up from 20.5% in the third quarter of 2023. The 30% improvement in gross profit year-over-year, or 8.3% improvement quarter-on-quarter, highlights the continuous success of the Company's margin improvement initiatives, including data licensing programs, mix optimization and supply chain productivity initiatives.

  • Operating loss was $18.5 million for the third quarter of 2024, driven by a negative valuation adjustment of equity-accounted investees (SunStream portfolio) of $13.4 million and restructuring charges of $1.9 million. This compares to a loss of $16.4 million in the third quarter of 2023, which included a favorable equity-accounted investees valuation adjustment of $6.6 million. Excluding the volatility of these non-cash valuation adjustments, we continue to see material improvements in profitability.

  • Cash flow was positive by $80.0 million in the third quarter of 2024, compared to $16.5 million in the third quarter of 2023, as a result of profitability improvements and the repayment of loan investments. Year-to-date cash flow is positive by $67.9 million.

  • Free cash flow in the third quarter of 2024 was positive $9.2 million, compared to $16.3 million in the third quarter of 2023. This result brings year-to-date free cash flow to negative $2.8 million, compared to negative $62.3 million in the first nine months of 2023. SNDL is on pace to deliver positive free cash flow for the 2024 calendar year, in line or ahead of guidance.

  • Third quarter results reflect dynamic 8% net revenue growth from our combined Cannabis businesses, while reaching a new record high gross margin, despite continued softness in Liquor sales. In addition to continued operational improvements, the following examples highlight strategic initiatives driving SNDL towards sustained profitable growth:

    • Completed the acquisition of the principal indebtedness of Delta 9 for a purchase price of $28.1 million in early July, becoming its senior secured creditor with a first-priority security interest in all assets of Delta 9 and certain of its subsidiaries.
    • By mid-July we announced a restructuring program aimed at reducing corporate overheads, improving organizational efficiency, and delivering ongoing annualized savings of over $20 million. The program is on track with more than $2 million savings delivered in the third quarter ($10.3 million annualized).
    • SNDL collected US$73 million in early August from SunStream, following the loan repayment to SunStream representing a majority of Ascend's outstanding balance and the full outstanding balance of Jushi.
    • SNDL's stalking horse bid was chosen as the successful bid in the acquisition of the Indiva Group's business and assets, as announced on August 29. This acquisition has closed and positions SNDL as the market leader in the Canadian edibles category.
    • On October 21, SNDL announced the closing of the plan of arrangement pursuant to which SNDL has privatized Nova Cannabis Inc. through the acquisition of the remaining minority equity interest.

  • The Company had $763.8 million of unrestricted cash, marketable securities and investments and no outstanding debt, with $263.0 million of unrestricted cash as of September 30, 2024. Subsequent to the end of the quarter, $37.3 million was used to pay the cash consideration portion of the acquisition of Nova's minority equity interest. SNDL has not raised cash through share offerings since June 2021.

"We are pleased with the substantial progress reflected in our results for the third quarter of 2024 as we advance towards sustainable profitability. Our team delivered a record gross margin, positive cash flow and free cash flow, and closed the quarter with over a quarter billion dollars in unrestricted cash and zero debt. We are materially improving our operational performance while executing multiple strategic initiatives that we believe will solidify our foundation and drive sustained, profitable growth," said Zach George, Chief Executive Officer of SNDL. "Our strong balance sheet serves as a beacon for future opportunities, allowing us to thoughtfully deploy capital into organic and inorganic investments with attractive, risk-adjusted returns. I am more confident than ever that our team - setting new records with each quarter - has the expertise and drive to unlock SNDL's significant potential."

THIRD QUARTER 2024 KEY FINANCIAL METRICS

OPERATING SEGMENTS



















($000s)

Liquor

Retail


Cannabis

Retail


Cannabis

Operations


Investments


Corporate


Total


Three months ended September 30, 2024



















Net revenue


144,565



81,144



25,007



-



(13,824)



236,892


Gross profit


36,951



20,710



5,307



-



-



62,968


Operating income (loss)


11,795



4,395



(703)



(7,824)



(26,174)



(18,511)


Adjusted operating income (loss) (1)


11,795



4,395



(578)



(7,824)



(24,381)



(16,593)


Three months ended September 30, 2023



















Net revenue


151,801



75,539



20,954



-



(10,699)



237,595


Gross profit


37,263



20,046



(8,704)



-



-



48,605


Operating income (loss)


8,278



3,432



(13,957)



9,886



(24,023)



(16,384)


Adjusted operating income (loss) (1)


8,278



3,432



(14,153)



9,886



(22,992)



(15,549)


(1)

Adjusted operating income (loss) is a specified financial measure that does not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similar measures reported by other companies. See "Non-IFRS Measures - Adjusted operating income (loss)" below.


THIRD QUARTER 2024 RESULTS

SNDL's business is operated and reported in four segments: Liquor Retail, Cannabis Retail, Cannabis Operations and Investments.

Liquor Retail

SNDL is Canada's largest private sector liquor retailer, operating 166 locations, predominantly in Alberta, under its three retail banners: "Wine and Beyond", "Liquor Depot", and "Ace Liquor".

  • Net revenue for Liquor Retail sales was $144.6 million in the third quarter of 2024, compared to $151.8 million for the same period in the year prior. The 4.8% reduction year-over-year was driven by overall market slow-down in customer traffic.
  • Same-store sales decreased by 5.0% for stores operating in the third quarters of 2023 and 2024. Same-store sales refer to the revenue generated by the Company's existing retail liquor locations, which operated during the current and comparative periods.
  • Gross profit for Liquor Retail was $37.0 million, or 25.6% of sales, in the third quarter of 2024, compared to $37.3 million, or 24.5% of sales, in the third quarter of 2023. The Company achieved record gross margin for its Liquor Retail segment in August of 2024, with margins reaching 26.5%, mainly driven by productivity in procurement, mix management and pricing optimization initiatives.
  • Operating income for Liquor Retail was $11.8 million in the third quarter of 2024, compared to $8.3 million in the third quarter of 2023, an impressive 42.5% improvement despite lower revenue.
  • SNDL's proprietary data licensing program for Liquor Retail which launched in the first quarter of 2024, saw a 23% increase in revenue compared to the prior quarter.

As of November 4, 2024, the Ace Liquor store count was 134, the Liquor Depot store count was 19, and the Wine and Beyond store count was 13.

Cannabis Retail

SNDL is Canada's ?largest private-sector cannabis retailer by number of stores, operating 187 locations under its three retail banners: "Value Buds", "Spiritleaf", and "Superette". The Company's Cannabis Retail strategy is based on several pillars, including the quality of its store locations, its range of products, and the unique experiences provided to customers. Using data and insights from a large volume of monthly transactions enables SNDL to leverage technology and analytics to inform and improve its retail strategy.

  • Net revenue for Cannabis Retail in the third quarter of 2024 was $81.1 million, compared to $75.5 million in the third quarter of 2023. The 7.4% increase year-over-year was driven by productivity improvements and new stores opened throughout the year.
  • Same-store sales increased 2.3% for stores operating in the third quarters of 2023 and 2024, in line with the first half of the year. Same-store sales refer to the revenue generated by the Company's existing retail cannabis locations, which operated during the current and comparative periods.
  • Gross profit for Cannabis Retail was $20.7 million, or 25.5% of sales, in the third quarter of 2024, compared to $20.0 million, or 26.5% of sales, in the third quarter of 2023, a 3.3% increase year-over-year.
  • Operating income for Cannabis Retail was $4.4 million in the third quarter of 2024, compared to $3.4 million in the third quarter of 2023, an increase of 28.1% year-over-year.
  • SNDL's proprietary data licensing program generated revenue of $4.0 million for the third quarter of 2024, in line with the same period in the year prior.

As of November 4, 2024, the Spiritleaf store count was 81 (20 corporate stores and 61 franchise stores), the Superette store count was 4 corporate stores, and the Value Buds store count was 102 corporate stores.

Cannabis Operations

SNDL has a diverse brand portfolio from value to premium, emphasizing premium inhalable formats and a full suite of 2.0 products. With enhanced procurement capabilities and plans to continue evolving toward a cost-effective cultivation and manufacturing operation, the Cannabis Operations segment is a key enabler of SNDL's vertical integration strategy.

  • Net revenue for Cannabis Operations for the third quarter of 2024 was $25.0 million, up 19.3% from $21.0 million in the third quarter of 2023, mainly as a result of increasing provincial board and Business-to-Business distribution and a continued focus on consumer innovation, quality and operational efficiencies.
  • We are encouraged by the strong demand for our products, as evidenced by the opening of 71 new distribution points during the third quarter and the increase in international orders for the fourth quarter.
  • Gross profit for the segment in the third quarter of 2024 of $5.3 million, an increase of $14.0 million from negative $8.7 million in the third quarter of 2023. The record gross margin of 21.2% for the segment is supported by a strong productivity program.
  • Operating income for the third quarter of 2024 improved by $13.3 million over the same period in the prior year, going from negative $14.0 million to negative $0.7 million. The substantial increase in operating income results from margin expansion, reduced overhead spending, and operational efficiencies.

Investments

  • As of September 30, 2024, the Company has deployed capital to a portfolio of cannabis-related investments with a carrying value of $500.4 million, including $451.1 million to SunStream Bancorp Inc. ("SunStream"). This carrying value was reduced by $100.1 million during the third quarter of 2024, mainly driven by the cash collections on outstanding loan balances to SunStream from Ascend Wellness Holdings, Inc. ("Ascend") and Jushi Holdings Inc. ("Jushi").
  • In July 2024, Ascend repaid approximately 80% of their outstanding loan balance with SunStream, amounting to US$12 million. On July 31, 2024, Jushi repaid their full outstanding balance of US$53 million with SunStream. Both repayments occurred several months ahead of the maturity date, increasing SNDL's cash liquidity and enabling the deployment of additional capital to support our growth agenda.
  • In the third quarter of 2024, the investment portfolio generated negative operating income of $7.8 million, including a $13.4 million negative valuation adjustment of equity-accounted investees (SunStream portfolio). This compares to a positive operating income of $9.9 million in the third quarter of 2023, which included a favorable $6.6 million valuation adjustment of equity-accounted investees.
  • SunStream is a joint venture sponsored by SNDL. During 2023, SunStream directed the formation of the SunStream USA group of companies ("SunStream USA Group") in connection with the restructuring of certain loans provided by SunStream. SunStream USA Group is anticipated to be a U.S. platform with one or more independent third-party investors, which will be independently managed and governed.
  • During the third quarter of 2024, the credit portfolio controlled by SunStream comprised five investments: Jushi, SKYMINT Brands ("Skymint"), Ascend, Surterra Holdings, Inc. d/b/a Parallel ("Parallel"), and Columbia Care Inc.
  • The previously announced transactions to acquire certain operations and assets of Parallel and Skymint continue to be subject to certain conditions and regulatory approvals.
  • SNDL continues to monitor local and international regulatory changes, including the potential reclassification of marijuana from a Schedule I drug to Schedule III drug under the U.S. Controlled Substances Act, or the outcome of amendment 3 vote to legalize recreational marijuana for adults aged 21 and older in Florida. These decisions do not directly affect SNDL's operations, which are located solely in Canada, though they would have a favorable effect on the SunStream joint venture investments in the United States.

Equity Position

  • $763.8 million of unrestricted cash, marketable securities and investments, including investments in equity-accounted investees, and no outstanding debt at September 30, 2024, resulting in a net book value of $1.2 billion.
  • Subsequent to the three months ended September 30, 2024, SNDL issued 159,792 shares as the share consideration for the acquisition of Nova's minority equity interest, in addition to the $37.7 million in cash consideration mentioned above.
  • On November 13, 2023, the Company announced that its board of directors had approved a renewal of the share repurchase program upon its expiry on November 20, 2023. The Company's share repurchase program continues to be available to lower the outstanding share float. SNDL will continue to assess opportunities to utilize the program to the extent that management believes it is in the best interest of SNDL's shareholders. Subsequent to the quarter end, in October 2024 the Company repurchased 59,417 common shares for cancellation under the share repurchase program at a price of US$1.90 per share.

This press release is intended to be read in conjunction with the Company's condensed consolidated interim financial statements and the notes thereto for the three and nine months ended September 30, 2024, and the accompanying Management's Discussion and Analysis. These documents are available under the Company's profile on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov/edgar.shtml.

CONFERENCE CALL

The Company will hold a conference call and webcast presentation at 10:00 a.m. EST (8:00 a.m. MST) on Tuesday, November 5, 2024.

WEBCAST ACCESS
To access the live webcast of the call, please visit the following link:

https://edge.media-server.com/mmc/p/fjuij37h

REPLAY

A replay of the webcast will be available at https://sndl.com/financials/quarterly-results/default.aspx

ABOUT SNDL INC.

SNDL is a public company whose shares are traded on the Nasdaq under the symbol "SNDL." SNDL is the largest private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf, Superette and Firesale. SNDL is a licensed cannabis producer and one of the largest vertically integrated cannabis companies in Canada specializing in low-cost biomass sourcing, indoor cultivation, product innovation, low-cost manufacturing facilities,?and a cannabis brand portfolio that includes Top Leaf, Contraband, Citizen Stash, Sundial Cannabis, Palmetto, Spiritleaf Selects Bon Jak, Versus, Value Buds, Namaste, Re-up, Grasslands and Vacay. SNDL's investment portfolio seeks to deploy strategic capital through direct and indirect investments and partnerships throughout the North American cannabis industry.?For more information on SNDL, please go to?https://sndl.com/.?

Forward-Looking Information Cautionary Statement???

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"), including, but not limited to, statements regarding the Company's operational goals, the Company's margin improvement initiatives, the Company's ability to achieve long-term, sustainable profitability, growth and efficiencies, the Company's long-term strategic plan, expectations with respect to the restructuring project, the benefits of the Company's Investment Segment portfolio, expectations with respect to sharing information with investors, the Company's approach to its Wine and Beyond banner, the Company's retail strategy, expectations with respect to the Company's Cannabis Operations segment, the Company's vertical integration strategy, expectations with respect to the Company's pursuit of EU-GMP certification, expectations with respect to the ability of the Company's to expand its international export footprint, the Company's proprietary data licensing program, expansion of product offerings (including the expected expansion of the Company's private labels), performance of the Company's investments, including through the SunStream joint venture and SunStream USA Group, expectations with respect to the SunStream USA Group, the timing and closing of the transactions with Parallel and Skymint, potential local and international regulatory changes, the share repurchase program, including the anticipated benefits thereof, and any other potential forms of shareholder value creation. Forward-looking statements are frequently characterized by words such as "aim", "anticipate", "assume", "believe", "contemplate", "continue", "could", "due", "estimate", "expect", "goal", "intend", "may", "objective", "plan", "predict", "potential", "positioned", "pioneer", "seek", "should", "target", "will", "would", and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the Company's business and the industry in which it operates and management's beliefs and assumptions and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond its control. Forward-looking statements are based on the opinions and estimates of management at the date the statements are?made and?are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Please see "Risk Factors" in the?Company's Annual Information Form dated March 20, 2024, and the risk factors included in our other public disclosure documents for?a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether?as a result of?new information, future events or otherwise, except as expressly required by applicable law.???

Condensed Consolidated Interim Statement of Loss and Comprehensive Loss
(Unaudited - expressed in thousands of Canadian dollars, except per share amounts)



Three months ended

September 30




2024



2023


Net revenue



236,892




237,595


Cost of sales



173,924




188,990


Gross profit



62,968




48,605











Investment income



5,577




3,416


Share of profit (loss) of equity-accounted investees



(13,401)




6,581











General and administrative



49,980




48,235


Sales and marketing



2,813




3,271


Research and development



76




57


Depreciation and amortization



13,389




15,545


Share-based compensation



5,702




5,373


Restructuring (recovery) costs



1,918




708


Asset impairment



(258)




1,783


Loss on disposition of assets



35




14


Operating income (loss)



(18,511)




(16,384)











Other income (expenses)



609




(5,443)


Loss before income tax



(17,902)




(21,827)


Income tax recovery (expense)



(1,434)




-


Net loss from continuing operations



(19,336)




(21,827)


Net loss from discontinued operations



-




-


Net loss



(19,336)




(21,827)











Equity-accounted investees - share of other comprehensive income (loss)



(4,802)




11,124


Comprehensive income (loss)



(24,138)




(10,703)











Net loss from continuing operations attributable to:









Owners of the Company



(19,328)




(21,784)


Non-controlling interest



(8)




(43)





(19,336)




(21,827)


Net loss attributable to:









Owners of the Company



(19,328)




(21,784)


Non-controlling interest



(8)




(43)





(19,336)




(21,827)


Comprehensive income (loss) attributable to:









Owners of the Company



(24,130)




(10,660)


Non-controlling interest



(8)




(43)





(24,138)




(10,703)



Condensed
Consolidated Interim Statement of Financial Position
(Unaudited - expressed in thousands of Canadian dollars)

As at


September 30, 2024


December 31, 2023








Assets






Current assets






Cash and cash equivalents



262,976



195,041


Restricted cash



20,215



19,891


Marketable securities



483



225


Accounts receivable



24,589



27,059


Biological assets



901



429


Inventory



127,863



129,060


Prepaid expenses and deposits



15,507



22,464


Investments



22,900



3,400


Assets held for sale



19,051



6,375


Net investment in subleases



2,927



2,970





497,412



406,914


Non-current assets






Long-term deposits and receivables



3,702



4,837


Right of use assets



118,409



129,679


Property, plant and equipment



128,310



152,916


Net investment in subleases



16,820



18,396


Intangible assets



77,019



73,149


Investments



26,413



29,660


Equity-accounted investees



451,068



538,331


Goodwill



123,924



119,282


Total assets



1,443,077



1,473,164








Liabilities






Current liabilities






Accounts payable and accrued liabilities



54,038



68,210


Lease liabilities



34,541



30,537


Derivative warrants



52



4,400





88,631



103,147


Non-current liabilities






Lease liabilities



122,959



136,492


Other liabilities



7,214



4,185


Total liabilities



218,804



243,824








Shareholders' equity






Share capital



2,383,233



2,375,950


Warrants



667



2,260


Contributed surplus



81,591



73,014


Contingent consideration



2,279



2,279


Accumulated deficit



(1,288,505)



(1,260,851)


Accumulated other comprehensive income



28,949



19,417


Total shareholders' equity



1,208,214



1,212,069


Non-controlling interest



16,059



17,271


Total liabilities and shareholders' equity



1,443,077



1,473,164



Condensed Consolidated Interim Statement of Cash Flows
(Unaudited - expressed in thousands of Canadian dollars)





Three months ended
September 30







2024



2023



Cash provided by (used in):










Operating activities










Net loss for the period





(19,336)




(21,827)



Adjustments for:










Income tax expense





1,434




-



Interest and fee income





(5,577)




(3,445)



Change in fair value of biological assets





167




1,819



Share-based compensation





5,702




5,373



Depreciation and amortization





13,970




16,602



Loss on disposition of assets





35




14



Inventory impairment and obsolescence





413




9,126



Finance costs, net





1,740




2,142



Change in estimate of fair value of derivative warrants





(3,848)




2,840



Unrealized foreign exchange loss





80




68



Asset impairment (reversal)





(258)




1,783



Share of (profit) loss of equity-accounted investees





13,401




(6,581)



Realized loss on settlement of marketable securities





-




46,082



Unrealized (gain) loss on marketable securities





-




(46,053)



Additions to marketable securities





(327)




-



Proceeds from settlement of marketable securities





-




3,241



Income distributions from equity-accounted investees





10,715




-



Interest received





4,496




3,325



Change in non-cash working capital





(13)




13,033



Net cash provided by operating activities from continuing operations





22,794




27,542



Net cash provided by operating activities from discontinued operations





-




-



Net cash provided by operating activities





22,794




27,542



Investing activities










Additions to property, plant and equipment





(1,706)




(3,042)



Additions to intangible assets





(2,421)




(32)



Changes to investments





(18,952)




195



Capital distributions from equity-accounted investees





89,758




-



Proceeds from disposal of property, plant and equipment





-




1,150



Change in non-cash working capital





(191)




730



Net cash provided by (used in) investing activities





66,488




(999)



Financing activities










Change in restricted cash





(243)




(205)



Payments on lease liabilities, net





(9,780)




(9,793)



Change in non-cash working capital





783




(17)



Net cash used in financing activities





(9,240)




(10,015)



Change in cash and cash equivalents





80,042




16,528



Cash and cash equivalents, beginning of period





182,934




185,455



Cash and cash equivalents, end of period





262,976




201,983




NON-IFRS MEASURES
Certain specified financial measures in this news release are non-IFRS measures. These terms are not defined by IFRS and, therefore, may not be comparable to similar measures reported by other companies. These non-IFRS financial measures should not be considered in isolation or as an alternative for or superior to measures of performance prepared in accordance with IFRS.?These measures are presented and described in order to provide shareholders and potential investors with additional measures in understanding the Company's operating results in the same manner as the management team.?

ADJUSTED OPERATING INCOME (LOSS)
Adjusted operating income (loss) is a non-IFRS financial measure which the Company uses to evaluate its operating performance. Adjusted operating income (loss) provides information to investors, analysts, and others to aid in understanding and evaluating the Company's operating results in a similar manner to its management team. The Company defines adjusted operating income (loss) as operating income (loss) less restructuring costs (recovery), goodwill and intangible asset impairments and asset impairments triggered by restructuring activities.

The following tables reconcile adjusted to un-adjusted operating income (loss) for the periods noted.

($000s)

Liquor

Retail


Cannabis

Retail


Cannabis

Operations


Investments


Corporate


Total


Three months ended September 30, 2024


Operating income (loss)


11,795



4,395



(703)



(7,824)



(26,174)



(18,511)


Adjustments:



















Restructuring costs


-



-



125



-



1,793



1,918


Adjusted operating income (loss)


11,795



4,395



(578)



(7,824)



(24,381)



(16,593)


($000s)

Liquor

Retail


Cannabis

Retail


Cannabis

Operations


Investments


Corporate


Total


Three months ended September 30, 2023



















Operating income (loss)


8,278



3,432



(13,957)



9,886



(24,023)



(16,384)


Adjustments:



















Restructuring costs (recovery)


-



-



(323)



-



1,031



708


Intangible asset impairments


-



-



127



-



-



127


Adjusted operating income (loss)


8,278



3,432



(14,153)



9,886



(22,992)



(15,549)



FREE CASH FLOW

Free cash flow is a non-IFRS financial measure which the Company uses to evaluate its financial performance. Free cash flow provides information which management believes to be useful to investors, analysts and others in understanding and evaluating the Company's ability to generate positive cash flows as it removes cash used for non-operational items. The Company defines free cash flow as the total change in cash and cash equivalents less cash used for common share repurchases, dividends (if any), changes to debt instruments, changes to long-term investments, net cash used for acquisitions plus cash provided by dispositions (if any).

The following table reconciles free cash flow to change in cash and cash equivalents for the periods noted.



Three months ended
September 30



Nine months ended
September 30


($000s)


2024



2023



2024



2023


Change in cash and cash equivalents (Cash Flow)



80,042




16,528




67,935




(77,603)


Adjustments













Repurchase of common shares



-




-




-




1,536


Changes to long-term investments



(70,806)




(195)




(72,342)




17,496


Acquisitions, net of cash acquired



-




-




1,654




(3,695)


Free cash flow



9,236




16,333




(2,753)




(62,266)


SOURCE SNDL Inc.

For more information:? Tomas Bottger, SNDL Inc., O: 1.587.327.2017, E:?[email protected]

© 2024 PR Newswire
5 heiße Wetten für den Jahresendspurt!
Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.